EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB)

被引：0

作者：

Schwarz, Kathleen B. ^{[1
]}

Bezerra, Jorge A. ^{[2
]}

Choe, Byung Ho ^{[3
,4
]}

Lin, Chuan-Hao ^{[5
]}

Abramov, Frida ^{[6
]}

Wang, Hongyuan ^{[6
]}

Liu, Yang ^{[6
]}

Flaherty, John F. ^{[6
]}

Pacurar, Daniela ^{[7
]}

Kim, Kyung Mo ^{[8
]}

Khaertynova, Ilsiyar ^{[9
]}

Shalimar ^{[10
]}

Wu, Jia-Feng ^{[11
]}

Tandon, Manish ^{[12
]}

Rosenthal, Philip ^{[13
]}

Morozov, Viacheslav ^{[14
]}

Sokal, Etienne M. ^{[15
]}

Chang, Mei Hwei ^{[16
,17
]}

机构：

[1] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA

[2] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[3] Kyungpook Natl Univ, Sch Med, Daegu, South Korea

[4] Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea

[5] Childrens Hosp Los Angeles, Los Angeles, CA USA

[6] Gilead Sci Inc, Foster City, CA USA

[7] Carol Davila Univ Med & Pharm, Bucharest, Romania

[8] Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea

[9] Kazan State Med Univ, Kazan, Russia

[10] All India Inst Med Sci, Delhi, India

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

[14] Hepatolog Med Co, Samara, Russia

[15] Clin Univ St Luc, Brussels, Belgium

[16] Natl Taiwan Univ, Taipei, Taiwan

[17] Children Hosp, Taipei, Taiwan

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1414C

引用

页码：S515 / S517

页数：3

共 50 条

[11] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) VS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN EAST ASIAN CHRONIC HEPATITIS B PATIENTS FOLLOWING 5-YEARS OF TREATMENT
Wong, Grace Lai Hung
Gane, Edward
Pan, Calvin
Lim, Young-Suk
Fung, Scott
Izumi, Namiki
Ma, Mang
Chan, Carol Yee Kwan
Shalimar, Dr
Buti, Maria
GUT, 2021, 70 : A76 - A76
[12] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 96 WEEKS IN CHRONIC HBV (CHB) PATIENTS WITH RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE (TDF)
Chan, Henry Lik-Yuen
Buti, Maria
Flisiak, Robert
Ryder, Stephen
Streinu-Cercel, Adrian
Flaherty, John F.
Gaggar, Anuj
Mo, Shuyuan
Subramanian, G. Mani
Zoulim, Fabrian
Andreone, Pietro
Marcellin, Patrick
GUT, 2018, 67 : A97 - A97
[13] Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice
Curry, Michael
Bae, Ho
Dieterich, Douglas
Ankoma-Sey, Victor
Reddy, Rajender
Pan, Calvin
Hann, Hie-Won
Tong, Myron
Kim, W. Ray
Kwo, Paul
Frazier, Lynn
Milligan, Scott
Spitz, Keith
Afdhal, Nezam
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E462 - E462
[14] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay
Ning, Qin
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin O.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott
Shalimar
Brunetto, Maurizia
Flaherty, John
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward
Hou, Jinlin
Buti, Maria
GUT, 2020, 69 : A75 - A76
[15] Efficacy and Safety of Tenofovir Alafenamide (TAF) at 96 Weeks in Chronic HBV (CHB) Patients with Risk Factors for Use of Tenofovir Disoproxil Fumarate (TDF)
Buti, Maria
Stepanova, Tatjana
Celen, Mustafa K.
Flisiak, Robert
Ryder, Stephen D.
Streinu-Cercel, Adrian
Gurel, Selim
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Mo, Shuyuan
Subramanian, Mani
Nurmukhametova, Elena
Zoulim, Fabien
Andreone, Pietro
Marcellin, Patrick
HEPATOLOGY, 2017, 66 : 488A - 488A
[16] SEQUENTIAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) IN PATIENTS WITH CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSIS OF AN ONGOING MULTINATIONAL PROSPECTIVE STUDY
Ogawa, Eiichi
Toyoda, Hidenori
Jun, Dae Won
Hsu, Yao-Chun
Yoon, Eileen
Ahn, Sang Bong
Yeh, Ming-Lun
Yasuda, Satoshi
Kawashima, Keigo
Do, Son T.
Trinh, Huy N.
Takahashi, Hirokazu
Enomoto, Masaru
Tseng, Cheng-Hao
Inoue, Kaori
Haga, Hiroaki
Maeda, Mayumi
Kam, Leslie
Cheung, Ramsey
Ueno, Yoshiyuki
Eguchi, Yuichiro
Furusyo, Norihiro
Yu, Ming-Lung
Tanaka, Yasuhito
Nguyen, Mindie H.
HEPATOLOGY, 2020, 72 : 495A - 496A
[17] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
Agarwal, Kosh
Fung, Scott
Seto, Wai-Kay
Lim, Young-Suk
Gane, Edward
Janssen, Harry L.
Chuang, Wan-Long
Bae, Ho
Yoon, Ki Tae
Flaherty, John F.
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Cathcart, Andrea
Lin, Lanjia
Chan, Alain
Shalimar, Mani Subramanian
Furusyo, Norihiro
Buti, Maria
Chan, Henry L.
GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086
[18] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lim, Young-Suk
Chan, Henry Lik Yuen
Seto, Wai-Kay
Ning, Qing
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin Q.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott K.
Shalimar
Brunetto, Maurizia R.
Flaherty, John F.
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward J.
Hou, Jinlin
Buti, Maria
HEPATOLOGY, 2019, 70 : 126A - 127A
[19] Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with renal impairment: week 48 results from a phase 2 open label study
Janssen, Harry
Lampertico, Pietro
Chen, Chi-Yi
Heo, Jeong
Fournier, Claire
Ahn, Sang Hoon
Tsang, Tak Yin Owen
Coffin, Carla
Reggiani, Giulio Marchesini
Huang, Yi-Hsiang
Hui, Aric Josun
Elkhashab, Magdy
Chen, Chien-Hung
Jafri, Syed Mohammed Raza
Tan, Susanna
Mo, Shuyuan
Suri, Vithika
Flaherty, John F.
Gaggar, Anuj
Subramanian, Mani
Agarwal, Kosh
Chuang, Wan-Long
Gane, Edward
Lim, Young-Suk
JOURNAL OF HEPATOLOGY, 2020, 73 : S866 - S867
[20] Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study
Bae, Ho S.
Lim, Young-Suk
Trinh, Huy
Heo, Jeong
Chuang, Wan-Long
Hui, Aric Josun
Elkhashab, Magdy
Tan, Susanna K.
Mo, Shuyuan
Guion, Matthew
Jump, Belinda
Flaherty, John
Suri, Vithika
Gaggar, Anuj
Tsang, Tak Yin Owen
Andreone, Pietro
Janssen, Harry
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S567 - S567

← 1 2 3 4 5 →